Bapineuzumab.com Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 13 years ago on Saturday, August 14, 2010, according to the United State Patent & Trademark Office
Word Mark Bapineuzumab.Com
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Janssen Alzheimer Immunotherapy

View all trademarks for Janssen Alzheimer Immunotherapy

Previous Owners

Elan Pharmaceuticals, Inc. of South San Francisco, CA

View all trademarks for Elan Pharmaceuticals, Inc.
Other Trademarks for Elan Pharmaceuticals, Inc.
Serial Number 77701313
Status Date Saturday, August 14, 2010
Filing Date Saturday, August 14, 2010
Attorney Laurence S. Rickles
Domestic Representative Laurence S. Rickles

Correspondent

Laurence S. Rickles
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick NJ 08933-7001

Case File Statements

Goods & Services Providing a web site featuring medical information
Pseudo Mark Bapineuzumab

Classifications

International Class Codes
044 — Class 44 includes mainly medical care, hygienic and beauty care given by persons or establishments to human beings and animals; it also includes services relating to the fields of agriculture, horticulture and forestry.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Tuesday, March 31, 2009
Primary Code 044

You must be signed in to print.

Once signed in, look for the PDF button.